What is the NCCN recommendation for use of PET scanning in the treatment of early-stage, unfavorable Hodgkin lymphoma (Hodgkin disease)?

Updated: Sep 12, 2018
  • Author: Bradley W Lash, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

In addition, as with early-stage favorable Hodgkin lymphoma, there is controversy regarding the role of interim positron emission tomography (PET) scanning. As with early-stage favorable disease, the NCCN endorses the use of PET scanning for restaging. How this impacts survival is not known, but mid-treatment PET scanning remains an option. If this imaging modality is performed, biopsy of positive sites is mandatory before changing treatment.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!